Ledger.Open graph →
SEC Form D · filed February 12, 2021

Acrivon Therapeutics, Inc

Offering
$15.5M
Sold
$15.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Eric Devroe · Cambridge, MAExecSharon Shacham · Newton, MADirectorPeter Blume-Jensen · Cambridge, MAExec · DirectorKristina Masson · Cambridge, MAExec · DirectorMarcin Czernik · Cambridge, MADirectorSharon Shacham · Cambridge, MADirectorPeter Blume-Jensen · Cambridge, MAExec · DirectorKristina Masson · Cambridge, MAExec · DirectorMarcin Czernik · Cambridge, MADirectorEric Devroe · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗